Reader responses to "Mission Critical: The Future of Davis-Monthan" series.
You have to wonder if this is a fair way to wind down a failing business.
The transmitter, foreground, and receiver designed by chief scientist Rick Gerdes of Medusa Scientific send and receive multiple channels of data.
Everyone's heard of AM and FM. Are you ready for TM?
Chief scientist Rick Gerdes, left, and CEO Dan Hodges of Medusa Scientific watch a monitor as it displays multiple channels of data. The company says its modulation technology will multiply data transmission for cellular, satellite and radio communications.
Science Foundation Arizona's boost to the state's tech sector is still rippling out into the economy, even as it has turned its focus to technology education, according to the most recent annual report card on the nonprofit tech foundation.
Tucson is home to a new unmanned aircraft technology company, but it's been here all along.
The Manta for geoscience research, shown during testing in Greenland, is one of the small unmanned aerial systems produced by Sensintel Inc., formed by Tucson businessman Matthew Pobloske.
While many college students will spend this summer catching some waves, some University of Arizona students are catching the next wave in medicine.
A Tucson-area company that has long specialized in predicting failure is prognosticating success with technology to help scientists unlock the secret life of atoms.
Esko Mikkola, a senior principal engineer with Ridgetop Group, Inc., will lead the work. He poses here with a slide of the Large Hadron Collider, one of the accelerators that might use the company's chip.
CEO of Ridgetop Group, Inc.
Tucson's Critical Path Institute recently got some good news - and some noteworthy recognition - when the U.S. Senate gave final approval to a budget reauthorization bill including the Food and Drug Administration partnership program that helps fund the institute.
Research investigator Joseph Kim works in a lab at Sanofi's drug-research center in Oro Valley. The Tucson-based Critical Path Institute has brought Sanofi and other major drug companies together to share data and help speed effective, targeted therapies to market.